Taysha Gene Therapies, Inc. / Insider Transactions

    Source Name Title Transaction Date Shares Price Value

    Configure table

    Control which columns are visible

    Export the current table view as a CSV file, which you can open in programs like Excel or Google Sheets.
    SEC Alam Kamran CHIEF FINANCIAL OFFICER -54K $2.85 -$155.30K
    SEC Nagendran Sukumar President and Head of R&D -57K $2.85 -$162.60K
    SEC Manning Paul B N/A +750K $2.75 +$2.06M
    SEC Manning Paul B N/A +1.3M $2.25 +$3.00M
    SEC Manning Paul B N/A +100K $1.63 +$163.00K
    SEC Alam Kamran Chief Financial Officer -33K $2.33 -$76.89K
    SEC Donenberg Phillip B. N/A +111K $0.90 +$100.00K
    SEC Manning Paul B N/A +16M $0.90 +$14.82M
    SEC Nolan Sean P. Chief Executive Officer +444K $0.90 +$400.00K
    SEC Stalfort John A III N/A +778K $0.90 +$700.00K
    SEC Session R.A. II N/A -86K $0.71 -$60.97K
    SEC Session R.A. II N/A -29K $0.70 -$20.03K
    SEC Session R.A. II N/A -435K $0.71 -$308.58K
    SEC Nagendran Sukumar President and Head of R&D +5K $0.68 +$3.40K
    SEC Manning Paul B N/A +1.5M $2.00 +$3.00M
    SEC Alam Kamran Chief Financial Officer -3.3K $3.47 -$11.54K
    SEC Alam Kamran Chief Financial Officer -29K $3.70 -$106.10K
    SEC PRASAD SUYASH CMO and Head of R&D -13K $3.70 -$47.59K
    SEC PRASAD SUYASH CMO and Head of R&D -50K $3.65 -$183.01K
    SEC Manning Paul B N/A +202K $7.80 +$1.57M
    SEC Donenberg Phillip B. N/A +3K $7.78 +$23.34K
    SEC Nagendran Sukumar N/A +10K $8.01 +$80.10K
    SEC Manning Paul B N/A +2.2K $13.19 +$29.04K
    SEC Manning Paul B N/A +20K $12.54 +$250.80K
    SEC Session R.A. II President and CEO +43K $12.44 +$528.92K
    SEC Alam Kamran Chief Financial Officer -33K $16.88 -$557.04K
    SEC PRASAD SUYASH CMO and Head of R&D -79K $22.63 -$1.79M
    SEC Nolan Sean P. N/A +1.2K $22.35 +$26.15K
    SEC Manning Paul B N/A +12K $20.98 +$251.76K

    Notifications